These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35047396)

  • 41. Recombinant human endostatin combined with chemotherapy for advanced squamous cell lung cancer: a meta-analysis.
    Feng L; Wang Z; Jing L; Zhou Z; Shi S; Deng R; Liu Y; Meng Q
    World J Surg Oncol; 2021 Feb; 19(1):64. PubMed ID: 33637113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial.
    Blay JY; Pápai Z; Tolcher AW; Italiano A; Cupissol D; López-Pousa A; Chawla SP; Bompas E; Babovic N; Penel N; Isambert N; Staddon AP; Saâda-Bouzid E; Santoro A; Franke FA; Cohen P; Le-Guennec S; Demetri GD
    Lancet Oncol; 2015 May; 16(5):531-40. PubMed ID: 25864104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
    Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304).
    Tanaka K; Mizusawa J; Fukuda H; Araki N; Chuman H; Takahashi M; Ozaki T; Hiruma T; Tsuchiya H; Morioka H; Hatano H; Iwamoto Y
    Jpn J Clin Oncol; 2015 Jun; 45(6):555-61. PubMed ID: 25838293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Efficacy and safety of rh-endostatin combined with docetaxel in second-line or intolerant toxicity for first-line treatment in patients with advanced non-small cell lung cancer].
    Wang J; Li K; Sun T; Zhang MJ; Li WL; Yao Q; Liu W; Ding CM; He ZY; Mao WD; Wang HM; Zhang Y; Zhou XL
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):618-22. PubMed ID: 24314222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pleural synovial sarcoma patient treated with combined chemotherapy and Endostar, plus sunitinib maintenance therapy: A case report and review of the literature.
    Teng C; Li LI; Shen W; Li J; Liu Y; Jiang Q; Xin T; Huang D; Song X; Lv Y; Jin Y
    Oncol Lett; 2015 Aug; 10(2):1141-1144. PubMed ID: 26622640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endostar combined with irinotecan/calcium folinate/5-fluorouracil (FOLFIRI) for treating advanced colorectal cancer: A clinical study.
    Li BL; Hu XL; Zhao XH; Sun HG; Zhou CY; Zhang Y
    J Chemother; 2015 Oct; 27(5):301-6. PubMed ID: 25873343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer.
    Lu S; Li L; Luo Y; Zhang L; Wu G; Chen Z; Huang C; Guo S; Zhang Y; Song X; Yu Y; Zhou C; Li W; Liao M; Li B; Xu L; Chen P; Hu C; Hu C
    J Thorac Oncol; 2015 Jan; 10(1):206-11. PubMed ID: 25654728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
    Tap WD; Jones RL; Van Tine BA; Chmielowski B; Elias AD; Adkins D; Agulnik M; Cooney MM; Livingston MB; Pennock G; Hameed MR; Shah GD; Qin A; Shahir A; Cronier DM; Ilaria R; Conti I; Cosaert J; Schwartz GK
    Lancet; 2016 Jul; 388(10043):488-97. PubMed ID: 27291997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846.
    Liu X; Xu J; Li F; Liao Z; Ren Z; Zhu L; Shi Y; Zhao G; Bai X; Zhao J; Xing R; Teng S; Yang Y; Yang J
    Biomed Pharmacother; 2020 Feb; 122():109587. PubMed ID: 31786466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and efficacy of nivolumab plus recombinant human endostatin in previously treated advanced non-small-cell lung cancer.
    Lv W; Pei X; Zhao W; Cong Y; Wei Y; Li T; Zhang H; Lin Z; Saito Y; Kim JJ; Liang Z; Zhong B; Wang Z
    Transl Lung Cancer Res; 2022 Feb; 11(2):201-212. PubMed ID: 35280309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE study.
    Nakano K; Motoi N; Inagaki L; Tomomatsu J; Gokita T; Ae K; Tanizawa T; Shimoji T; Matsumoto S; Takahashi S
    Jpn J Clin Oncol; 2015 May; 45(5):449-55. PubMed ID: 25724217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis.
    Thway K; Fisher C
    Semin Diagn Pathol; 2021 Nov; 38(6):170-186. PubMed ID: 34602314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
    Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
    Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical observation of Endostar® combined with chemotherapy in advanced colorectal cancer patients.
    Xu HX; Huang XE; Qian ZY; Xu X; Li Y; Li CG
    Asian Pac J Cancer Prev; 2011; 12(11):3087-90. PubMed ID: 22393994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China.
    Li F; Liao Z; Zhao J; Zhao G; Li X; Du X; Yang Y; Yang J
    Oncotarget; 2017 Sep; 8(38):64471-64480. PubMed ID: 28969086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study.
    García Del Muro X; Maurel J; Martínez Trufero J; Lavernia J; López Pousa A; de Las Peñas R; Cubedo R; Berros JP; Casado Herráez A; de Juan A; Martín Broto J
    Invest New Drugs; 2018 Jun; 36(3):468-475. PubMed ID: 29527631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma.
    Wang HY; Chu JF; Zhang P; Wang JQ; Yan Z; Yao SN; Yao ZH; Liu YY
    Onco Targets Ther; 2020; 13():1561-1568. PubMed ID: 32110053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA".
    Schöffski P; Toulmonde M; Estival A; Marquina G; Dudzisz-Śledź M; Brahmi M; Steeghs N; Karavasilis V; de Haan J; Wozniak A; Cousin S; Domènech M; Bovée JVMG; Charon-Barra C; Marreaud S; Litière S; De Meulemeester L; Olungu C; Gelderblom H
    Eur J Cancer; 2021 Jul; 152():26-40. PubMed ID: 34062484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
    Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
    Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.